Pricing Log in Create free account
Saturday 17 October 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

104.88 0.20 +0.19%
Market cap
$181.1B
P/E
33.9×
Fwd P/E
22.9×
Dividend yield
2.40%
F-score
5/9
Altman Z
5.61
Beneish M
−2.50
Dividend safety
62/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Abbott Laboratories (ABT) Shares outstanding

Alert me on Shares outstanding

Abbott Laboratories's shares outstanding at the end of fiscal 2025 was $1.7B, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $1.7B. Over the past ten years it has ranged from $1.5B (fiscal 2016) to $1.8B (fiscal 2021); the current reading is higher than 36% of that period. Abbott Laboratories ranks 1st of 147 Medical Devices companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2025 $1.7B 0.00%
FY2024 $1.7B (0.06%)
FY2023 $1.7B (0.85%)
FY2022 $1.8B (1.40%)
FY2021 $1.8B 0.17%
FY2020 $1.8B 0.28%
FY2019 $1.8B 0.62%
FY2018 $1.8B 1.20%
FY2017 $1.7B 17.94%
FY2016 $1.5B (1.53%)

Quarterly newest first

Period Shares outstanding Change
Jun 2026 $1.7B (0.23%)
Mar 2026 $1.7B (0.05%)
Dec 2025 $1.7B (0.08%)
Sep 2025 $1.7B (0.08%)
42 more quarters

Against its own ten years

Low $1.5B High $1.8B
Ten-year median $1.7B
Current reading's percentile 36

Shares outstanding against peers

Company Shares outstanding
ABT Abbott Laboratories $1.7B
BSX Boston Scientific Corporation compare $1.5B
MDT Medtronic PLC compare $1.3B
PHG Koninklijke Philips N.V. compare $968.6M
EW Edwards Lifesciences Corporation compare $577.6M
GEHC GE HealthCare Technologies Inc. compare $454.0M
DXCM DexCom, Inc. compare $390.1M
SYK Stryker Corporation compare $386.0M
STE STERIS plc compare $97.9M

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on ABT